Related Experiment Videos
Multidrug-resistant tuberculosis in a lung transplant recipient
Joseph Lee1, Wing Wai Yew, Chi Fong Wong
1Tuberculosis and Chest Unit, Grantham Hospital, 125 Wong Chuk Hang Road, Aberdeen, Hong Kong SAR, China. josephlee59@yahoo.com
Summary
Multidrug-resistant tuberculosis is a growing threat after lung transplants, especially in endemic regions. This case highlights the risk of donor-transmitted infection and challenges in managing post-transplant tuberculosis.
Area of Science:
- Pulmonology
- Infectious Diseases
- Transplantation Immunology
Background:
- Lung transplantation is a life-saving procedure for end-stage lung diseases.
- Tuberculosis (TB) is a rare but serious complication following lung transplantation.
- The rise of multidrug-resistant tuberculosis (MDR-TB) poses a significant threat in endemic regions.
Observation:
- This report details the first case of MDR-TB in a double-lung transplant recipient.
- The infection was likely transmitted from the organ donor.
- The patient presented with complications related to post-transplant MDR-TB.
Findings:
- Successful management of post-transplant MDR-TB is challenging due to drug resistance and immunosuppression.
- Donor-derived TB transmission is a critical consideration in lung transplant recipients from endemic areas.
- Early diagnosis and tailored treatment regimens are crucial for patient outcomes.
Implications:
- Highlights the need for stringent donor screening protocols for tuberculosis in endemic regions.
- Underscores the importance of awareness and vigilance for MDR-TB in lung transplant recipients.
- Informs clinical management strategies for post-transplant infectious complications, particularly drug-resistant tuberculosis.